After experiencing a health crisis from an adverse response to medication used to treat eczema, Kelly was propelled into the world of advocacy. Her passion to support those suffering as she had, led her to serve on several national and international dermatology non-profits, bringing awareness to the great needs of the eczema and TSW communities in academic, regulatory and political arenas.
Kelly serves as president of the Coalition of Skin Diseases, a group of national non-profit skin-related patient groups, which advocates for the 84+ million Americans living with skin conditions. She also serves on the Board of Directors of the patient advocacy group, ITSAN, and sits on the Patient Advocacy and Drug Transparency Task Forces of the American Academy of Dermatology and the Atopic Eczema Advisory Group for Globalskin.
